The company
Stevanato Group S.p.A.
STVN · NYSE
STVN stood above a rising 150-day average in 11 of the last 52 weekly readings, including each of the last 8 weeks. It is 2.1% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 8 in a row
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $1.1M
- Officials’ trades on record
- 0
- Institutions holding
- 118 (-4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Mauro StocchiOfficer | sold | 13,649at $21.50 | 28 Sep 2026filed 30 Sep 2026 |
| Elisabetta MagistrettiDirector | sold | 2,045at $20.09 | 7 Aug 2026filed 10 Aug 2026 |
| Lago Marco DalChief Financial Officer | sold | 4,209at $20.09 | 7 Aug 2026filed 10 Aug 2026 |
| Luciano SantelDirector | sold | 2,023at $20.09 | 7 Aug 2026filed 10 Aug 2026 |
| William J. FedericiDirector | sold | 1,493at $17.09 | 15 Jun 2026filed 26 Jun 2026 |
| Karen FlynnDirector | sold | 1,493at $17.09 | 15 Jun 2026filed 26 Jun 2026 |
| Donald E. Morel, Jr.Director | sold | 1,493at $17.09 | 15 Jun 2026filed 26 Jun 2026 |
| Madhavan BalachandranDirector | sold | 1,493at $17.09 | 15 Jun 2026filed 26 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Conestoga Capital Advisors, LLCreduced · filed 24 Jul 2026 | 7,007,613$126.6M | -1,484,138−17.5% |
| NEUBERGER BERMAN GROUP LLCadded · filed 13 Aug 2026 | 5,622,269$101.6M | +1,146,777+25.6% |
| TimesSquare Capital Management, LLCreduced · filed 7 Aug 2026 | 3,474,641$62.8M | -15,075−0.4% |
| Artisan Partners Limited Partnershipadded · filed 13 Aug 2026 | 2,601,598$47.0M | +311,538+13.6% |
| BAMCO INCreduced · filed 14 Aug 2026 | 2,494,871$45.1M | -5,567−0.2% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 1,305,306$23.6M | -11,229−0.9% |
| CREDIT AGRICOLE S Aadded · filed 14 Aug 2026 | 1,297,755$23.5M | +926,285+249.4% |
| WELLINGTON MANAGEMENT GROUP LLPnew · filed 14 Aug 2026 | 1,251,844$22.6M | +1,251,844 |
| Ranger Investment Management, L.P.reduced · filed 13 Aug 2026 | 1,186,375$21.4M | -84,436−6.6% |
| ROYCE & ASSOCIATES LPadded · filed 14 Aug 2026 | 916,356$16.6M | +75,030+8.9% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.